Profile data is unavailable for this security.
About the company
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
- Revenue in HKD (TTM)7.87bn
- Net income in HKD488.95m
- Incorporated2000
- Employees3.89k
- LocationTong Ren Tang Technologies Co LtdNo. 20 South Sanhuan Middle RoadFengtai DistrictBEIJING 100079ChinaCHN
- Phone+86 1 087632888
- Websitehttps://www.tongrentangkj.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AIM Vaccine Co Ltd | 1.43bn | -304.78m | 3.79bn | 1.49k | -- | 1.01 | -- | 2.65 | -0.2507 | -0.2507 | 1.18 | 3.05 | 0.174 | 0.7724 | 1.12 | 931,534.60 | -3.71 | -8.04 | -6.66 | -12.31 | 71.80 | 79.64 | -21.32 | -39.38 | 0.5882 | -3.70 | 0.3341 | -- | 8.22 | 6.19 | 78.69 | -- | -7.20 | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -153.88m | 4.55bn | 197.00 | -- | 5.49 | -- | -- | -0.7667 | -0.7667 | 0.00 | 4.17 | 0.00 | -- | -- | 0.00 | -12.48 | -- | -13.69 | -- | -- | -- | -- | -- | 4.68 | -- | 0.2296 | -- | -- | -- | 32.53 | -- | -- | -- |
| Shandong Boan Biotechnology Co Ltd | 857.13m | 36.28m | 4.82bn | 714.00 | 121.78 | 1.93 | 36.55 | 5.63 | 0.0636 | 0.0636 | 1.51 | 4.01 | 0.2530 | 1.34 | 1.73 | 1,054,275.00 | 1.07 | -- | 1.41 | -- | 71.70 | -- | 4.23 | -- | 1.45 | 1.81 | 0.2827 | -- | 17.50 | -- | 161.31 | -- | -- | -- |
| VIVA Biotech Holdings | 2.08bn | 195.14m | 4.92bn | 2.09k | 32.59 | 1.11 | 9.78 | 2.37 | 0.0709 | 0.0709 | 0.6816 | 2.09 | 0.2612 | 4.24 | 4.94 | 1,008,351.00 | 3.22 | -1.28 | 3.81 | -1.56 | 37.44 | 34.30 | 12.33 | -4.94 | 1.44 | -- | 0.2283 | -- | -7.84 | 43.80 | 244.08 | -8.85 | 27.82 | -- |
| Tong Ren Tang Technologies Co Ltd | 7.87bn | 488.95m | 5.62bn | 3.89k | 11.50 | 0.6804 | 4.54 | 0.7145 | 0.3818 | 0.3818 | 6.14 | 6.45 | 0.482 | 0.8615 | 6.00 | 1,971,759.00 | 5.47 | 7.44 | 8.57 | 12.07 | 39.82 | 42.21 | 11.34 | 15.10 | 2.79 | -- | 0.1913 | 39.34 | 7.18 | 10.15 | -11.59 | 4.55 | -8.30 | 3.37 |
| Ocumension Therapeutics | 615.81m | -282.30m | 5.71bn | 505.00 | -- | 1.38 | -- | 9.27 | -0.3768 | -0.3768 | 0.8223 | 5.08 | 0.1571 | 4.30 | 3.35 | 1,259,321.00 | -7.20 | -24.03 | -7.62 | -25.71 | 42.58 | 58.38 | -45.84 | -400.90 | 4.86 | -- | 0.0223 | -- | 69.38 | 365.95 | 29.36 | -- | 213.01 | -- |
| Beijing Tong Ren Tang Chinese Medicine | 1.71bn | 515.36m | 7.39bn | 789.00 | 14.34 | 1.83 | 11.77 | 4.33 | 0.6157 | 0.6157 | 2.04 | 4.81 | 0.3878 | 0.4134 | 4.92 | 2,185,246.00 | 12.14 | 15.34 | 13.34 | 17.17 | 63.00 | 68.94 | 31.29 | 39.16 | 11.43 | -- | 0.0327 | 52.52 | 5.69 | 2.38 | -7.42 | -2.09 | 20.50 | 8.76 |
| China Shineway Pharmaceutical Group Ltd | 3.79bn | 938.05m | 8.03bn | 2.87k | 7.82 | 0.9079 | 10.30 | 2.12 | 1.24 | 1.24 | 5.01 | 10.70 | 0.3299 | 1.15 | 3.81 | 1,176,221.00 | 8.17 | 8.29 | 10.75 | 10.38 | 73.36 | 74.83 | 24.77 | 18.67 | 3.39 | -- | 0.0419 | 37.49 | -16.35 | 6.90 | -13.35 | 10.80 | 8.92 | 19.39 |
Data as of Feb 13 2026. Currency figures normalised to Tong Ren Tang Technologies Co Ltd's reporting currency: Hong Kong Dollar HKD
9.23%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 07 Jan 2026 | 24.18m | 3.85% |
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 12.82m | 2.04% |
| BlackRock Fund Advisorsas of 09 Jan 2026 | 10.22m | 1.63% |
| BlackRock Advisors (UK) Ltd.as of 09 Jan 2026 | 3.49m | 0.56% |
| UBS Asset Management (Hong Kong) Ltd.as of 31 Oct 2025 | 3.30m | 0.53% |
| American Century Investment Management, Inc.as of 08 Jan 2026 | 908.00k | 0.14% |
| SSgA Funds Management, Inc.as of 08 Jan 2026 | 895.00k | 0.14% |
| Thrivent Asset Management LLCas of 31 Oct 2025 | 794.00k | 0.13% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 747.56k | 0.12% |
| Vanguard Fiduciary Trust Co.as of 30 Nov 2025 | 685.69k | 0.11% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
